Fighting melanoma's attraction to the brain
(Medical Xpress)—The process of metastasis, by which cancer cells travel from a tumor site and proliferate at other sites in the body, is a serious threat to cancer patients. According to the National Cancer ...
Cancer
Sep 19, 2012 |
not rated yet |
0
|
Researchers find cause of chemotherapy resistance in melanoma
Researchers with UC Irvine's Chao Family Comprehensive Cancer Center have identified a major reason why melanoma is largely resistant to chemotherapy.
Cancer
Sep 17, 2012 |
not rated yet |
0
|
Cloned receptor paves way for new breast and prostate cancer treatment
Researchers at Uppsala University have cloned a T-cell receptor that binds to an antigen associated with prostate cancer and breast cancer. T cells that have been genetically equipped with this T-cell receptor have the ability ...
Cancer
Sep 13, 2012 |
4 / 5 (4) |
0
|
Missing pieces of DNA structure is a red flag for deadly skin cancer
Melanoma is the most dangerous type of skin cancer and is the leading cause of death from skin disease. Rates are steadily increasing, and although risk increases with age, melanoma is now frequently seen in young people.
Cancer
Sep 13, 2012 |
5 / 5 (1) |
0
|
Study identifies human melanoma stem cells
(Medical Xpress)—Cancer stem cells are defined by three abilities: differentiation, self-renewal and their ability to seed a tumor. These stem cells resist chemotherapy and many researchers posit their ...
Cancer
Aug 23, 2012 |
5 / 5 (3) |
1
|
Study reveals new molecular target for melanoma treatment
A laboratory study led by UNC medical oncologist Stergios Moschos, MD, demonstrates how a new targeted drug, Elesclomol, blocks oxidative phosphorylation, which appears to play essential role in melanoma that has not been ...
Cancer
Aug 17, 2012 |
5 / 5 (1) |
0
|
Combination therapy delivers one-two punch to skin cancer, boosting anti-tumor activity
(Medical Xpress) -- Treating metastatic melanoma by combining immunotherapy with a drug that inhibits the cancer-spreading activity of a common gene mutation significantly increased survival times in an animal model, according ...
Cancer
Aug 16, 2012 |
not rated yet |
0
|
Potential new treatment target identified for melanoma skin cancer
New research from Western University, Canada, has identified a potential new target for the treatment of melanoma, the deadliest of all skin cancers. Silvia Penuela and Dale Laird discovered a new channel-forming ...
Cancer
Aug 15, 2012 |
5 / 5 (2) |
0
|
Study suggests patients should be screened before receiving vemurafenib
Different genetic mistakes driving skin cancer may affect how patients respond to the drug vemurafenib, providing grounds to screen people with melanoma skin cancer before treatment, a new study by Cancer Research UK scientists ...
Cancer
Aug 14, 2012 |
not rated yet |
0
|
Detecting cancer with lasers has limited use, researchers say
One person dies every hour from melanoma skin cancer in the United States, according to the American Cancer Society. A technique, known as photoacoustics, can find some forms of melanoma even if only a few ...
Cancer
Jul 30, 2012 |
5 / 5 (1) |
0
|
New melanoma driver genes found in largest DNA sequencing study to date
(Medical Xpress) -- Yale Cancer Center geneticists, biochemists, and structural biologists have painted the most comprehensive picture yet of the molecular landscape of melanoma, a highly aggressive and often ...
Genetics
Jul 29, 2012 |
5 / 5 (4) |
0
|
People with darker skin still at risk for melanoma
(HealthDay) -- Skin cancer is more common among white people, but people with darker skin are also at risk, a dermatology expert cautions.
Cancer
Jul 26, 2012 |
5 / 5 (2) |
0
Scientists discover melanoma-driving genetic changes caused by sun damage
It's been a burning question in melanoma research: Tumor cells are full of ultraviolet (UV)-induced genetic damage caused by sunlight exposure, but which mutations drive this cancer?
Cancer
Jul 19, 2012 |
not rated yet |
0
|
Uncommon BRAF mutation in melanoma sensitive to MEK inhibitor drug therapy
An uncommon mutation of the BRAF gene in melanoma patients has been found to respond to MEK inhibitor drugs, providing a rationale for routine screening and therapy in melanoma patients who harbor the BRAF L597 mutation.
Cancer
Jul 16, 2012 |
not rated yet |
0
|
Researchers descover melanoma-promoting gene
Black skin cancer, also known as melanoma, is particularly aggressive and becoming increasingly common in Switzerland. Despite intensive research, however, there is still no treatment. Researchers from the ...
Cancer
Jul 10, 2012 |
not rated yet |
0
|
